Syner-G BioPharma Group, a provider of pharmaceutical science and regulatory consulting services, has acquired RMC Pharmaceutical Solutions (RMC). RMC supports the outsourced CMC and Quality needs of biotech and pharma companies across multiple therapeutic areas. Financial terms were not disclosed.
The acquisition provides additional pharmaceutical science services, adding development experience in all biologic modalities including cell and gene therapy. The combined team offers a range of process and analytical development services, regulatory strategy, regulatory submission support, and quality management services. For RMC, the acquisition provides biotech and pharma clients access to a full range of integrated development and regulatory services.
